VenatoRx Pharmaceuticals, Inc.

VenatoRx Pharmaceuticals, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2010-06-04
Employees
51
Market Cap
-
Website
http://www.venatorx.com

Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age

First Posted Date
2024-10-30
Last Posted Date
2024-11-11
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
31
Registration Number
NCT06665555
Locations
🇺🇸

Pulmonary Associates, Phoenix, Arizona, United States

Cefepime-taniborbactam Vs Meropenem in Adults with VABP or Ventilated HABP

First Posted Date
2023-12-13
Last Posted Date
2024-10-30
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
316
Registration Number
NCT06168734

Food Effect on Ceftibuten/VNRX-7145 in Healthy Participants

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-09-06
Last Posted Date
2023-07-18
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
24
Registration Number
NCT05527834
Locations
🇺🇸

ICON Plc., Lenexa, Kansas, United States

Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function

Phase 1
Completed
Conditions
Interventions
First Posted Date
2022-08-04
Last Posted Date
2023-12-22
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
32
Registration Number
NCT05488678
Locations
🇺🇸

Nucleus Network, Saint Paul, Minnesota, United States

🇺🇸

Orlando Clinical Research Center, Orlando, Florida, United States

🇺🇸

Advanced Pharma, Miami, Florida, United States

Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2021-07-06
Last Posted Date
2021-10-01
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
30
Registration Number
NCT04951505
Locations
🇺🇸

Pulmonary Associates PA, Phoenix, Arizona, United States

VNRX-7145 Drug-Drug Interaction in Healthy Adult Volunteers

First Posted Date
2021-05-07
Last Posted Date
2022-06-15
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
53
Registration Number
NCT04877379
Locations
🇳🇱

PRA Health Sciences - Early Development Services, Groningen, Netherlands

VNRX-9945 Safety and Pharmacokinetics in Healthy Adult Volunteers

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2021-04-14
Last Posted Date
2022-06-21
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
32
Registration Number
NCT04845321
Locations
🇳🇿

New Zealand Clinical Research, Auckland, New Zealand

VNRX-5024 Safety and PK in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2020-03-19
Last Posted Date
2022-06-15
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
36
Registration Number
NCT04314206
Locations
🇳🇱

PRA Health Sciences - Early Development Services, Groningen, Netherlands

VNRX-7145 SAD/MAD Safety and PK in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Interventions
First Posted Date
2020-01-28
Last Posted Date
2022-06-15
Lead Sponsor
Venatorx Pharmaceuticals, Inc.
Target Recruit Count
83
Registration Number
NCT04243863
Locations
🇺🇸

Worldwide Clinical Trials Early Phase Services, LLC, San Antonio, Texas, United States

© Copyright 2024. All Rights Reserved by MedPath